Cove Fund

Cove Fund is a venture capital firm based in Irvine, California, established in 2014. It specializes in providing seed-stage funding to early-stage technology and life science companies located in Southern California. The firm focuses on investing in promising startups that have the potential to develop differentiated products and services, aiming to create significant value through their initial investments. By targeting innovative ventures, Cove Fund seeks to support companies that are poised for impactful growth in their respective markets.

Steve Petilli

Venture Partner

Paul Voois

Fund Manager

J.C. Ruffalo

Venture Partner

Past deals in 3D Printing

BLNG

Seed Round in 2025
BLNG is a generative AI company specializing in design software and data products tailored for the jewelry industry. It offers AI-powered tools that empower creators to personalize jewelry designs, enhancing the creative process and enabling users to forge meaningful connections with their creations. By leveraging advanced AI technology, BLNG transforms the jewelry design experience and helps businesses realize the potential of AI-driven solutions, positioning itself as a leader in the future of personalized jewelry design.

Carlsmed

Series B in 2022
Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.

Carlsmed

Series A in 2020
Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.

Carlsmed

Seed Round in 2020
Carlsmed is a medical technology company based in San Diego, California, founded in 2018. It specializes in developing innovative solutions for spine surgery, notably through its proprietary aprevo™ digital-to-device 3-D printed implant system. This system is recognized as the first surgical implant to receive FDA designation as a breakthrough technology, reflecting its potential to enhance patient outcomes. Carlsmed focuses on personalized medicine, particularly in lumbar fusion surgery, by utilizing machine learning and historical outcomes data to tailor treatments for complex adult spinal deformities. The company aims to improve surgical results while also reducing healthcare costs associated with spine surgery, making it a valuable partner for hospitals and surgeons nationwide.

icClarity

Seed Round in 2016
icClarity, Inc. is a technology company based in Irvine, California, founded in May 2014. The company specializes in developing innovative 3-dimensional image capturing solutions that utilize a single imager, an illumination source, and an efficient firmware stack. This unique approach allows for the processing of raw sensor data to produce usable 3D coordinates, which can be integrated into various applications through a user-friendly API. icClarity's solutions are designed to meet the growing demand for high-resolution, full-rate 3D image capture without the extensive power requirements typically associated with multi-sensor systems. The company's technology is applicable across a wide range of industries, including security and surveillance, automotive, gaming, webcams, medical systems, and smartphones. Currently, icClarity is in the final stages of producing its first mass-production device, with expectations to begin shipping shortly.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.